- Home
- BCBP vs STTK Comparison
BCBP vs STTK Comparison
Compare BCBP & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- STTK
- Stock Information
- Founded
- BCBP 2000
- STTK 2016
- Country
- BCBP United States
- STTK United States
- Employees
- BCBP N/A
- STTK N/A
- Industry
- BCBP Savings Institutions
- STTK Biotechnology: Pharmaceutical Preparations
- Sector
- BCBP Finance
- STTK Health Care
- Exchange
- BCBP Nasdaq
- STTK Nasdaq
- Market Cap
- BCBP 136.5M
- STTK 112.6M
- IPO Year
- BCBP N/A
- STTK 2020
- Fundamental
- Price
- BCBP $8.21
- STTK $1.93
- Analyst Decision
- BCBP Hold
- STTK Hold
- Analyst Count
- BCBP 2
- STTK 5
- Target Price
- BCBP $9.50
- STTK $3.00
- AVG Volume (30 Days)
- BCBP 65.5K
- STTK 393.0K
- Earning Date
- BCBP 10-17-2025
- STTK 11-13-2025
- Dividend Yield
- BCBP 8.12%
- STTK N/A
- EPS Growth
- BCBP N/A
- STTK N/A
- EPS
- BCBP 0.19
- STTK N/A
- Revenue
- BCBP $65,498,000.00
- STTK $2,997,000.00
- Revenue This Year
- BCBP $23.31
- STTK N/A
- Revenue Next Year
- BCBP $6.72
- STTK N/A
- P/E Ratio
- BCBP $41.25
- STTK N/A
- Revenue Growth
- BCBP N/A
- STTK N/A
- 52 Week Low
- BCBP $7.54
- STTK $0.69
- 52 Week High
- BCBP $14.04
- STTK $2.71
- Technical
- Relative Strength Index (RSI)
- BCBP 47.19
- STTK 47.43
- Support Level
- BCBP $7.87
- STTK $1.78
- Resistance Level
- BCBP $8.16
- STTK $2.14
- Average True Range (ATR)
- BCBP 0.20
- STTK 0.21
- MACD
- BCBP 0.00
- STTK -0.05
- Stochastic Oscillator
- BCBP 55.82
- STTK 19.90
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About STTK Shattuck Labs Inc.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.